XML 228 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY/(DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Mezzanine Equity Preferred Stock
Additional Paid-in Capital
Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2024 0 [1]         0  
Ending balance, temporary equity at Dec. 31, 2024 $ 0         $ 0 $ 0
Beginning balance (in shares) at Dec. 31, 2023 [2]   1,966,425          
Beginning balance at Dec. 31, 2023 114,471 $ 19 $ 943,960 $ (831,872) $ 2,364    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 13,342   13,342        
Forward Purchase Agreement Settlement 24,084   24,084        
Repurchase of equity instruments (48)   (48)        
Net loss (137,731)     (137,731)      
Issuance of common stock upon exercise of options and vesting of RSUs (in shares) [2]   11,997          
Issuance of common stock upon exercise of options and vesting of RSUs 300   300        
Treasury Shares (in shares) [2]   (29,265)          
Other comprehensive income, net (1,096)       (1,096)    
Foreign currency translation $ 125       125    
Ending balance (in shares) at Dec. 31, 2024 1,949,157 [1] 1,949,157 [2]          
Ending balance at Dec. 31, 2024 $ 13,447 $ 19 981,638 (969,603) 1,393    
Increase (Decrease) in Temporary Equity [Roll Forward]              
Issuance of preferred stock, net of issuance costs (in shares)           20,000,000  
Issuance of preferred stock, net of issuance costs $ 13,169         $ 2 13,167
Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2025 20,000,000 [1]         20,000,000  
Ending balance, temporary equity at Dec. 31, 2025 $ 13,169         $ 2 $ 13,167
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 7,279   7,279        
Reclassification of PIPE warrant to equity 16,150   16,150        
Net loss $ (48,951)   (48,951)        
Issuance of common stock upon exercise of options and vesting of RSUs (in shares) 0 30,811 [3]          
Issuance upon conversion of the Convertible Note (in shares)   340,543          
Issuance upon conversion of the Convertible Note $ 8,132 $ 4 8,128        
Other comprehensive income, net 1,091       1,091    
Foreign currency translation $ (1,040)       (1,040)    
Ending balance (in shares) at Dec. 31, 2025 2,320,511 [1] 2,320,511 [3]          
Ending balance at Dec. 31, 2025 $ (3,892) $ 23 $ 1,013,195 $ (1,018,554) $ 1,444    
[1] All common stock share and per share data for all periods presented have been retroactively adjusted to reflect the 1-for-100 reverse stock split of the Company’s common stock and the decrease in the par value of the Company’s common stock from $0.0001 to $0.0000001 per share which became effective on August 18, 2025
[2] All common stock share and per share data for all periods presented have been retroactively adjusted to reflect the 1-for-100 reverse stock split of the Company’s common stock and the decrease in the par value of the Company’s common stock from $0.0001 to $0.0000001 per share which became effective on August 18, 2025. See Note 2, “Summary of Significant Accounting Policies” for further information.
[3] All common stock share and per share data for all periods presented have been retroactively adjusted to reflect the 1-for-100 reverse stock split of the Company’s common stock and the decrease in the par value of the Company’s common stock from $0.0001 to $0.0000001 per share which became effective on August 18, 2025. See Note 2, “Summary of Significant Accounting Policies” for further information.